Novel IkB kinase inhibitors for treatment of nuclear factor-kB-related diseases

Expert Opin Investig Drugs. 2011 Mar;20(3):395-405. doi: 10.1517/13543784.2011.559162.


Introduction: NF-kB is a key regulator of inflammation and immunity in cancer development. The IkB kinase (IKK) is a multisubunit complex containing catalytic subunits termed IKK-α, -β and -γ. It is well known that many pro-inflammatory stimuli require the IKK-β subunit for NF-kB activation.

Areas covered: NF-kB affects the progression of inflammation-related diseases,such as myocardial ischemia, bronchial asthma, arthritis, cancer and other diseases. We review the characteristics and effects of these inhibitors on inflammatory and other diseases.

Expert opinion: Various synthesized IKK inhibitors have been developed and they will be used clinically in the near future.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • I-kappa B Kinase / antagonists & inhibitors*
  • I-kappa B Kinase / metabolism
  • Inflammation / drug therapy*
  • Inflammation / enzymology
  • Inflammation / metabolism
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism


  • NF-kappa B
  • I-kappa B Kinase